Xspire Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XSPIRE PHARMA, and what generic alternatives to XSPIRE PHARMA drugs are available?
XSPIRE PHARMA has six approved drugs.
There are two US patents protecting XSPIRE PHARMA drugs.
There are one hundred and fifty-five patent family members on XSPIRE PHARMA drugs in thirty-seven countries and twenty-two supplementary protection certificates in sixteen countries.
Drugs and US Patents for Xspire Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xspire Pharma | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072267-001 | Aug 17, 1988 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Xspire Pharma | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | RX | Yes | Yes | 7,304,078 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Xspire Pharma | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 206615-001 | Aug 4, 2017 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xspire Pharma | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | RX | Yes | Yes | 7,713,999 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Xspire Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Xspire Pharma | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,235,567 | ⤷ Try a Trial |
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | 3,600,437 | ⤷ Try a Trial |
Xspire Pharma | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | 3,600,437 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Xspire Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2552786 | ⤷ Try a Trial |
Portugal | 1495018 | ⤷ Try a Trial |
Taiwan | 200526643 | ⤷ Try a Trial |
Norway | 20044963 | ⤷ Try a Trial |
South Africa | 200603686 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Xspire Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1495018 | PA2015027,C1495018 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VORAPAKSARAS; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119 |
1495018 | 34/2015 | Austria | ⤷ Try a Trial | PRODUCT NAME: VORAPAXAR, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/14/976 20150119 |
1495018 | 218 50011-2015 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: VORAPAXARIUMSULFAT; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150121 |
1495018 | 132016000023030 | Italy | ⤷ Try a Trial | PRODUCT NAME: VORAPAXAR, O UN SUO SALE O SOLVATO FARMACEUTICAMENTE ACCETTABILE(ZONTIVITY); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/976, 20150119 |
1495018 | S1500036 | Hungary | ⤷ Try a Trial | PRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: EU/1/14/976 20150119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.